HLA-E Antibody (Center) Blocking Peptide
€363.00
In stock
SKU
AC-BP8517c
Background:
HLA-E preferably binds to a peptide derived from the signal sequence of most HLA-A, -B, -C and -G molecules.
Other Names:
HLA class I histocompatibility antigen, alpha chain E, MHC class I antigen E, HLA-E, HLA-62, HLAE
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8517c was selected from the Center region of human HLA-E. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: HLA-E {ECO:0000303|PubMed:9486650, ECO:0000312|HGNC:HGNC:4962}
Gene ID: 3133
Primary Accession: P13747
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
HLA-E preferably binds to a peptide derived from the signal sequence of most HLA-A, -B, -C and -G molecules.
Other Names:
HLA class I histocompatibility antigen, alpha chain E, MHC class I antigen E, HLA-E, HLA-62, HLAE
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8517c was selected from the Center region of human HLA-E. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: HLA-E {ECO:0000303|PubMed:9486650, ECO:0000312|HGNC:HGNC:4962}
Gene ID: 3133
Primary Accession: P13747
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review